Your browser doesn't support javascript.
loading
Pre-existing TGF-ß-specific T-cell immunity in patients with pancreatic cancer predicts survival after checkpoint inhibitors combined with radiotherapy.
Mortensen, Rasmus Erik Johansson; Holmström, Morten Orebo; Lisle, Thomas Landkildehus; Hasselby, Jane P; Willemoe, Gro L; Met, Özcan; Marie Svane, Inge; Johansen, Julia; Nielsen, Dorte L; Chen, Inna M; Andersen, Mads Hald.
Afiliação
  • Mortensen REJ; National Center for Cancer Immune Therapy, Department of Oncology, Herlev Hospital, Herlev, Denmark.
  • Holmström MO; National Center for Cancer Immune Therapy, Department of Oncology, Herlev Hospital, Herlev, Denmark.
  • Lisle TL; Department of Immunology and Microbiology, Copenhagen University, Copenhagen, Denmark.
  • Hasselby JP; National Center for Cancer Immune Therapy, Department of Oncology, Herlev Hospital, Herlev, Denmark.
  • Willemoe GL; Department of Pathology, Rigshospitalet, Copenhagen, Denmark.
  • Met Ö; Department of Pathology, Rigshospitalet, Copenhagen, Denmark.
  • Marie Svane I; National Center for Cancer Immune Therapy, Department of Oncology, Herlev Hospital, Herlev, Denmark.
  • Johansen J; National Center for Cancer Immune Therapy, Department of Oncology, Herlev Hospital, Herlev, Denmark.
  • Nielsen DL; Department of Oncology, Herlev Hospital, Herlev, Denmark.
  • Chen IM; Department of Oncology, Herlev Hospital, Herlev, Denmark.
  • Andersen MH; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
J Immunother Cancer ; 11(3)2023 03.
Article em En | MEDLINE | ID: mdl-36948507

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Linfócitos T / Vacinas Anticâncer / Inibidores de Checkpoint Imunológico / Imunidade Celular Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Linfócitos T / Vacinas Anticâncer / Inibidores de Checkpoint Imunológico / Imunidade Celular Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article